| Drug Name |
Atracurium besylate |
| Drug ID |
BADD_D00188 |
| Description |
A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents. |
| Indications and Usage |
For use, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. |
| Marketing Status |
approved |
| ATC Code |
M03AC04 |
| DrugBank ID |
DB00732
|
| KEGG ID |
D00758
|
| MeSH ID |
D001279
|
| PubChem ID |
47320
|
| TTD Drug ID |
D0Q1PR
|
| NDC Product Code |
55150-216; 0409-1105; 0409-1109; 71288-701; 55486-1597; 71288-702; 55150-217; 17404-0008 |
| UNII |
40AX66P76P
|
| Synonyms |
Atracurium | 33 A 74 | A 74, 33 | Relatrac | Tracrium | BW-33A | BW 33A | BW33A | Atracurium Besylate | Atracurium Besilate | Besilate, Atracurium | Atracurium Dibesylate |
